These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25104509)

  • 1. Intrauterine contraception - what now and what next?
    Guillebaud J
    Eur J Contracept Reprod Health Care; 2001; 6 Suppl 1():11-4. PubMed ID: 25104509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine contraception--what now and what next?
    Guillebaud J
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():11-4. PubMed ID: 11336428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levonorgestrel intrauterine system: a clinical perspective from the UK.
    Guillebaud J
    Ann N Y Acad Sci; 2003 Nov; 997():185-93. PubMed ID: 14644825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The levonorgestrel intrauterine system: the benefits of reduced bleeding.
    Cameron IT
    Eur J Contracept Reprod Health Care; 2001; 6 Suppl 1():27-32. PubMed ID: 25104512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The levonorgestrel intrauterine system: the benefits of reduced bleeding.
    Cameron IT
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():27-32. PubMed ID: 11336431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The levonorgestrel intrauterine system: more than a contraceptive.
    Andersson K
    Eur J Contracept Reprod Health Care; 2001; 6 Suppl 1():15-22. PubMed ID: 25104510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levonorgestrel intrauterine system: more than a contraceptive.
    Andersson K
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():15-22. PubMed ID: 11336429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
    Wildemeersch D; Janssens D; Weyers S
    Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M; Odlind V
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
    Hubacher D; Masaba R; Manduku CK; Veena V
    Contraception; 2013 Jul; 88(1):97-102. PubMed ID: 23566383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestin-releasing intrauterine systems.
    Luukkainen T; Pakarinen P; Toivonen J
    Semin Reprod Med; 2001 Dec; 19(4):355-63. PubMed ID: 11727177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies.
    Apter D; Gemzell-Danielsson K; Hauck B; Rosen K; Zurth C
    Fertil Steril; 2014 Jun; 101(6):1656-62.e1-4. PubMed ID: 24726226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
    Römer T; Linsberger D
    Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.